Medizinische Universität Graz Austria - Forschungsportal - Medical University of Graz
EuroSTEC: Soft tissue engineering for congenital birth defects in children: from "biomatrix - cell interaction - model system" to clinical trials
- Abstract
- The aim of this project is to use modern tissue engineering approaches to treat children with structural disorders present at birth, such as spina bifida, urogenital defects or abdominal wall defects and surrounding anomalies. The project strives to elucidate underlying mechanisms and take a translational route through in vitro and animal experiments.
This project will give more insight in the opportunities for advanced technical possibilities with tissue engineering techniques and new treatment strategies for severe and major structural congenital birth defects in children.
- Projektleitung:
-
Saxena Amulya Kumar
- Laufzeit:
- 01.01.2007-31.12.2011
- Programm:
- EU (FP-6)
- Subprogramm
- TP1 (Deadline der Ausschreibung: 09.11.2005)
- EU-Projektinstrument
- Integrated Project (IP)
- Art der Forschung
- Angewandte Forschung
- Mitarbeiter/innen
- Saxena A., Projektleiter/in
- Beteiligte MUG-Organisationseinheiten
-
Klinische Abteilung für allgemeine Kinder- und Jugendchirurgie
- Projektpartner
-
Centre Hospitalier Universitaire Vaudois, Schweiz.
-
CuraTrial SMO & Research BV, Niederlande.
-
European Medical Contract Manufacturing (E.M.C.M.) B.V., Niederlande.
-
Institut d’Investigations Biomediques August Pi I Sunyer, Spanien.
-
Karl Storz GmbH & Co.KG, Deutschland.
-
Katholieke Universiteit Leuven, Leuven, Belgien.
-
Matricel GmbH, Deutschland.
-
Stichting Katholieke Universiteit - the Radboud University Nijmegen Medical Centre, Niederlande.
-
Symatese Biomateriaux, Frankreich.
-
The Fetal Medicine Foundation, Großbritannien.
-
Universitair Medisch Centrum Groningen, Niederlande.
-
University of Zurich, Zürich, Schweiz.
-
Uppsala University, Schweden.
- Gefördert durch
-
Europäische Kommission, Rue de la Loi, Brussels, Europäische Union
